LIGNOCAINE AND ADRENALINE INJECTION Solution For Injection Kenya - English - Pharmacy and Poisons Board

lignocaine and adrenaline injection solution for injection

norbrook kenya ltd old limuru road karuri p.o box 1287 00606 nairobi - lignocaine hydrochloride and adrenaline… - solution for injection - lignocaine hydrochloride 20mg/ml and adrenaline… - anesthetics for topical use

LIGNOCAINE 20 WITH ADRENALINE - 1-100,000 LOCAL ANAESTHETIC INJECTION Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

lignocaine 20 with adrenaline - 1-100,000 local anaesthetic injection

troy laboratories pty ltd - lignocaine hydrochloride; adrenaline tartrate - parenteral liquid/solution/suspension - lignocaine hydrochloride caine active 20.0 mg/ml; adrenaline tartrate hormone active 0.0182 mg/ml - anaesthetics/analgesics - cat | cattle | dog | horse | pigs | sheep | beef | bitch | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | - anaesthetic - local/general | general anaesthetic | immobiliser | local anaesthetic | premedication | sedative | tranquilliser | travel sickness

2% Xylocaine DENTAL with Adrenaline (epinephrine) 1:80,000 New Zealand - English - Medsafe (Medicines Safety Authority)

2% xylocaine dental with adrenaline (epinephrine) 1:80,000

dentsply sirona (nz) limited - adrenaline acid tartrate 0.0227mg equivalent to 12.5 µg adrenaline;  ; lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous - solution for injection - active: adrenaline acid tartrate 0.0227mg equivalent to 12.5 µg adrenaline   lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection - the product is indicated for the production of local nerve anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques. lidocaine solutions with adrenaline are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

LIDOCAINE-BAXTER lidocaine (lignocaine) hydrochloride (as monohydrate) 50 mg/5 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

lidocaine-baxter lidocaine (lignocaine) hydrochloride (as monohydrate) 50 mg/5 ml solution for injection ampoule

baxter healthcare pty ltd - lidocaine hydrochloride monohydrate, quantity: 53.3 mg (equivalent: lidocaine hydrochloride, qty 50 mg) - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium chloride; sodium hydroxide - for production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

LIDOCAINE-BAXTER lidocaine (lignocaine) hydrochloride (as monohydrate) 200 mg/20 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

lidocaine-baxter lidocaine (lignocaine) hydrochloride (as monohydrate) 200 mg/20 ml solution for injection vial

baxter healthcare pty ltd - lidocaine hydrochloride monohydrate, quantity: 213.2 mg (equivalent: lidocaine hydrochloride, qty 200 mg) - injection, solution - excipient ingredients: water for injections; sodium chloride; hydrochloric acid; sodium hydroxide - for production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

LIDOCAINE-BAXTER lidocaine (lignocaine) hydrochloride (as monohydrate) 40 mg/2 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

lidocaine-baxter lidocaine (lignocaine) hydrochloride (as monohydrate) 40 mg/2 ml solution for injection ampoule

baxter healthcare pty ltd - lidocaine hydrochloride monohydrate, quantity: 42.66 mg (equivalent: lidocaine hydrochloride, qty 40 mg) - injection, solution - excipient ingredients: sodium hydroxide; water for injections; sodium chloride; hydrochloric acid - for production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

LIDOCAINE-BAXTER lidocaine (lignocaine) hydrochloride (as monohydrate) 20 mg/2 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

lidocaine-baxter lidocaine (lignocaine) hydrochloride (as monohydrate) 20 mg/2 ml solution for injection ampoule

baxter healthcare pty ltd - lidocaine hydrochloride monohydrate, quantity: 21.32 mg (equivalent: lidocaine hydrochloride, qty 20 mg) - injection, solution - excipient ingredients: sodium hydroxide; sodium chloride; hydrochloric acid; water for injections - for production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

LIDOCAINE-BAXTER lidocaine (lignocaine) hydrochloride (as monohydrate) 400 mg/20 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

lidocaine-baxter lidocaine (lignocaine) hydrochloride (as monohydrate) 400 mg/20 ml solution for injection vial

baxter healthcare pty ltd - lidocaine hydrochloride monohydrate, quantity: 426.6 mg (equivalent: lidocaine hydrochloride, qty 400 mg) - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections; sodium hydroxide - for production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

LIDOCAINE-BAXTER lidocaine (lignocaine) hydrochloride (as monohydrate) 100 mg/5 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

lidocaine-baxter lidocaine (lignocaine) hydrochloride (as monohydrate) 100 mg/5 ml solution for injection ampoule

baxter healthcare pty ltd - lidocaine hydrochloride monohydrate, quantity: 106.65 mg (equivalent: lidocaine hydrochloride, qty 100 mg) - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; hydrochloric acid; water for injections - for production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.